Company / EPS (Basic)
Veracyte, Inc. EPS (Basic) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.02
FY2025
5-year range
-$1.11 / -$0.27
FY2021-FY2025
Trend
-100.0%
vs FY2024
Sector context
#123 of 160
Health Care
What the data says
Veracyte, Inc.'s eps (basic) of $-1.02 is lower than 77% of companies in the Health Care sector (FY2025). Improved from $-1.11 to $-1.02 over the past 2 years.
Based on SEC 10-K filings.
-1.02 in FY2025.
Improved from $-1.11 to $-1.02 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 160This company -$1.02 Sector average $1.66
▼
-161.6% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 100.0% year-over-year.
- Ranks #123 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2021.
- Lowest eps (basic) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.02 | -100.0% |
| FY2024 | -$0.51 | +54.1% |
| FY2023 | -$1.11 | -68.2% |
| FY2022 | -$0.66 | -144.4% |
| FY2021 | -$0.27 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026